CD8A and neoplasm: This is thought to be related to modifications to the major histocompatibility complex (MHC) antigen-presenting system, in which CD8+-MHC class I immunologic interaction drives selection pressure for loss of HLA class 1 loci in dominant tumor cell progenies [52,53,54,55].